Business Standard

Coronavirus outbreak: Don't panic over supplies, says pharma industry

Sun Pharma's Dilip Shanghvi said the industry and government were working closely to reduce dependence on one country

Pharma, medicine, drugs, Pharmaceuticals
Premium

Sohini DasNeha Alawadhi Mumbai/New Delhi
Amid rising cases of the novel coronavirus (Covid-19), the captains of Indian pharma industry on Friday said there was no reason to panic over drug supplies in the domestic market. The industry, however, was unanimous that high level of dependence on one geography for key raw materials had to be reduced to mitigate risks.

Meanwhile, Gujarat-based Cadila Healthcare has launched an accelerated research programme for developing a vaccine for Covid-19 with multiple teams in India and Europe. Pankaj R Patel, chairman of Cadila Healthcare, said the vaccine candidate should be ready in 8-10 months with support from the regulators. “We felt

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in